Diarrhea
|
0.110 |
Biomarker
|
phenotype |
BEFREE |
WNT2B deficiency should be considered for individuals with neonatal-onset diarrhea.
|
29909964 |
2018 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Strains KYC4030 and KYC4048 were determined to be <i>Myxococcus fulvus</i>, whereas strain KYC4081 was identified as <i>Corallococcus coralloides</i>.We found that metabolites of <i>M. fulvus</i> KYC4048 demonstrated no toxicity in normal cells but specifically induced cancer cell death by suppressing the expression of WNT2B.
|
29551019 |
2018 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Here, we describe our investigations of expression of WNT2B mRNAs in various types of human primary cancer.
|
11741304 |
2001 |
Primary malignant neoplasm
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Differential regulation of WNT2 and WNT2B expression in human cancer.
|
11712082 |
2001 |
Primary malignant neoplasm
|
0.040 |
Biomarker
|
group |
BEFREE |
Cancer gene therapy using an adenoviral vector expressing short hairpin RNA (shRNA) against Wnt2B was, therefore, found to have a strong antitumour effect against Wnt2B2-overexpressing tumours.
|
21646015 |
2012 |
Nasopharyngeal carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
The target gene of miR-185-3p, Wnt family member 2B (<i>WNT2B)</i> was silenced in 5-8F cells using siRNA in order to investigate its function in NPC.
|
28454443 |
2017 |
Nasopharyngeal carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma.
|
28053597 |
2017 |
Nasopharyngeal carcinoma
|
0.040 |
Biomarker
|
disease |
BEFREE |
Finally, the clinical significance of miRNA-324-3p and WNT2B was investigated in NPC tissues.
|
23583221 |
2013 |
Nasopharyngeal carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
We concluded that miR-185-3p contributed to the radioresistance of NPC via modulation of WNT2B expression in vitro.
|
25297925 |
2014 |
Malignant Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Strains KYC4030 and KYC4048 were determined to be <i>Myxococcus fulvus</i>, whereas strain KYC4081 was identified as <i>Corallococcus coralloides</i>.We found that metabolites of <i>M. fulvus</i> KYC4048 demonstrated no toxicity in normal cells but specifically induced cancer cell death by suppressing the expression of WNT2B.
|
29551019 |
2018 |
Malignant Neoplasms
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Differential regulation of WNT2 and WNT2B expression in human cancer.
|
11712082 |
2001 |
Malignant Neoplasms
|
0.030 |
Biomarker
|
group |
BEFREE |
Cancer gene therapy using an adenoviral vector expressing short hairpin RNA (shRNA) against Wnt2B was, therefore, found to have a strong antitumour effect against Wnt2B2-overexpressing tumours.
|
21646015 |
2012 |
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
These data suggest that Wnt2B indeed plays an important role in ovarian cancer metastasis and drug resistance.
|
22635028 |
2012 |
Neoplasm Metastasis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
The results of the present study indicate that miR-185-3p mediates the invasion and metastasis of NPC by targeting <i>WNT2B in vitro</i>.
|
28454443 |
2017 |
Polycystic Ovary Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B.
|
29917177 |
2018 |
Polycystic Ovary Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
Proliferation of Ovarian Granulosa Cells in Polycystic Ovarian Syndrome Is Regulated by MicroRNA-24 by Targeting Wingless-Type Family Member 2B (WNT2B).
|
31215527 |
2019 |
Tumor Progression
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Wnt2B overexpression is thought to affect tumour progression through the activation of the canonical Wnt pathway.
|
21646015 |
2012 |
Tumor Progression
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Wnt2B overexpression is thought to be involved in tumor progression through the activation of the canonical Wingless and INT-1 signaling pathway.
|
22635028 |
2012 |
ovarian neoplasm
|
0.020 |
Biomarker
|
disease |
BEFREE |
These data suggest that Wnt2B indeed plays an important role in ovarian cancer metastasis and drug resistance.
|
22635028 |
2012 |
Congenital Abnormality
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Expression Analysis of ACSL5 and Wnt2B in Human Congenital Pulmonary Airway Malformations.
|
30463708 |
2018 |
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Twenty-four genes are significantly different from adult, and 13 genes might be developing hippocampus-specific candidate genes, including wnt2b and some Alzheimer's disease-related genes.
|
12271469 |
2002 |
Brain Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
The results showed that the expression of Wnt5a (41/45), Wnt10b (37/45), and Wnt13 (35/45) were found in brain tumors, whereas Wnt1 (6/45) was shown to be less related.
|
12049819 |
2002 |
Non-Small Cell Lung Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
miR-577 suppresses cell proliferation and epithelial-mesenchymal transition by regulating the WNT2B mediated Wnt/β-catenin pathway in non-small cell lung cancer.
|
30015869 |
2018 |
Malignant tumor of cervix
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Among various cancer cell lines, the Wnt-13 mRNA was detected in HeLa (cervical cancer), MKN28 and MKN74 (gastric cancer).
|
8761309 |
1996 |
Primary biliary cirrhosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, both Wnt-13 and Notch transcripts are overexpressed in PBC liver.
|
11488641 |
2001 |